Fasting glucose and A1c can look normal for years while insulin resistance develops silently. Here’s the one test that catches it early, and why most panels skip it.
Every year, millions of people get their bloodwork back and hear the same thing: your glucose is normal, your A1c looks fine, your metabolism is healthy.
And they believe it. Because why wouldn’t they?
But glucose is one of the last metabolic markers to move. The test that would have caught it earlier, fasting insulin, was never ordered.
A routine metabolic panel typically includes fasting glucose and, in many cases, hemoglobin A1c. These are useful markers. But they measure the end result of a process, not the process itself.
Here’s what’s happening underneath a “normal” glucose reading. Your body is constantly working to keep blood sugar within a tight range. When cells start becoming resistant to insulin’s signal, the earliest stage of metabolic dysfunction, your pancreas responds by producing more insulin to compensate.[1]
Blood sugar stays normal. The glucose number looks fine. The A1c looks fine. But insulin is doing far more work than it should be.
This compensatory phase can persist for years, even decades, before glucose finally breaks out of range. The conventional markers look clean the entire time. The dysfunction is invisible on a standard panel because the standard panel isn’t measuring the right thing.
Fasting insulin measures how much insulin your body is producing at rest, in a fasted state. In a metabolically healthy person, that number is low. The body doesn’t need much insulin to maintain stable blood sugar because the cells are responding to it efficiently.
When insulin resistance is developing, fasting insulin climbs. The pancreas has to work harder to produce the same effect. That elevation can show up in labs years before glucose moves.[2]
This is the window where intervention is most effective. At this stage, insulin resistance is highly responsive to nutritional changes, resistance training, sleep optimization, and targeted support. The earlier it’s identified, the more options you have, and the less work it takes to reverse course.
By the time fasting glucose rises, you’ve already moved through the most reversible phase without knowing it.
This matters far beyond diabetes prevention. From a functional medicine perspective, insulin resistance is one of the most upstream drivers of chronic disease, and it shows up in conditions most people don’t immediately connect to blood sugar.
Elevated insulin promotes fat storage, particularly visceral fat, and inhibits the body’s ability to access stored fat for fuel. Patients who struggle to lose weight despite consistent effort often have undetected insulin resistance as a core driver.
Insulin directly influences sex hormone production and binding. In women, chronically elevated insulin is a primary driver of elevated androgens, a key mechanism in polycystic ovary syndrome.[5] In men, it’s linked to lower testosterone and changes in estrogen metabolism.
Insulin resistance precedes and drives many of the lipid changes associated with cardiovascular disease: elevated triglycerides, low HDL, and the shift toward small, dense LDL particles.[3][4] A normal cholesterol panel does not rule out this metabolic pattern.
Chronically elevated insulin promotes systemic low-grade inflammation and disrupts mitochondrial function. The fatigue, brain fog, and afternoon energy crashes many patients chalk up to stress or aging often have a metabolic root.
In each of these cases, identifying elevated fasting insulin early changes what’s possible. Not because fasting insulin is the only marker worth measuring, but because it gives you visibility into a process that standard panels miss entirely.
Fasting insulin is most informative in context. In a comprehensive functional medicine workup, it’s evaluated alongside:
| Marker | What It Adds |
|---|---|
| Fasting insulin | How hard your body is working to keep blood sugar stable |
| HOMA-IR | A calculated index from fasting insulin and fasting glucose that quantifies insulin resistance more precisely than either alone |
| Fasting glucose and HbA1c | The full glycemic picture |
| Triglycerides and HDL | The triglyceride-to-HDL ratio is a sensitive proxy for insulin resistance and cardiovascular risk |
| hs-CRP | The inflammatory load that often accompanies metabolic dysfunction |
| Sex hormones and thyroid | Metabolic and hormonal health are deeply interconnected, and dysfunction in one system rarely stays contained |
This is the difference between a snapshot and a full picture. A standard annual panel gives you one data point on a process that involves many moving parts. A complete metabolic workup gives you the information to actually understand what’s happening, and intervene before it becomes harder to reverse.
Download The Lab Work Your Provider Probably Isn’t Checking and get the complete list of functional medicine lab markers, including fasting insulin, HOMA-IR, and the full metabolic panel, that give you the earliest, most actionable picture of your metabolic health.
Free instant download. No spam, unsubscribe anytime.
Fasting insulin is not an exotic test. It’s inexpensive, widely available, and has been studied for decades. The reason it’s missing from standard panels is largely a function of how conventional medicine defines normal: by waiting for a marker to rise into the disease range before flagging it.
Functional medicine operates differently. The goal is to identify dysfunction at its earliest, most reversible stage, not to confirm disease after it’s already established.
If your bloodwork has only ever included glucose and A1c, you may be looking at a clean report that’s leaving out the most informative marker on the panel.
If you’re ready to go beyond standard bloodwork and get a real picture of what’s driving your symptoms, a discovery call is where we start.
Book a Discovery Call →Fasting glucose shows the end result of blood sugar regulation, not how hard your body is working to get there. When cells become resistant to insulin, the pancreas produces more insulin to compensate, so glucose and A1c can stay normal for years while insulin quietly rises.
It suggests your body needs more insulin than it should to keep blood sugar stable, which is an early sign of insulin resistance. It can appear years before fasting glucose rises out of range.
HOMA-IR is a calculated index that uses fasting insulin and fasting glucose together to quantify insulin resistance more precisely than either marker alone.
Beyond blood sugar, insulin resistance is linked to weight resistance and visceral fat, hormonal changes such as elevated androgens in PCOS and lower testosterone in men, cardiovascular lipid changes like high triglycerides and low HDL, and low-grade inflammation and fatigue.
A fuller metabolic picture pairs fasting insulin with HOMA-IR, fasting glucose and HbA1c, triglycerides and HDL, hs-CRP, and sex hormones and thyroid.
For educational purposes only. Not a diagnosis, and not a substitute for care from your healthcare provider. Talk with your provider about which labs are right for you.
